| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations
|
Salani, Ritu
|
|
2017
|
146 |
1 |
p. 3-10
|
artikel
|
| 2 |
Autoantibody biomarkers for the detection of serous ovarian cancer
|
Katchman, Benjamin A.
|
|
2017
|
146 |
1 |
p. 129-136
|
artikel
|
| 3 |
Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer
|
Swanick, Cameron W.
|
|
2017
|
146 |
1 |
p. 87-93
|
artikel
|
| 4 |
Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study
|
Kong, Yujia
|
|
2017
|
146 |
1 |
p. 81-86
|
artikel
|
| 5 |
Editorial Board
|
|
|
2017
|
146 |
1 |
p. i
|
artikel
|
| 6 |
Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer
|
Cohen, Joshua G.
|
|
2017
|
146 |
1 |
p. 146-152
|
artikel
|
| 7 |
Factors prognostic of survival in advanced-stage uterine serous carcinoma
|
Holman, Laura L.
|
|
2017
|
146 |
1 |
p. 27-33
|
artikel
|
| 8 |
Frequency of “incidental” serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study
|
Meserve, Emily E.K.
|
|
2017
|
146 |
1 |
p. 69-73
|
artikel
|
| 9 |
High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer
|
Veneris, Jennifer Taylor
|
|
2017
|
146 |
1 |
p. 153-160
|
artikel
|
| 10 |
HPV vaccines – A review of the first decade
|
Harper, Diane M.
|
|
2017
|
146 |
1 |
p. 196-204
|
artikel
|
| 11 |
Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer
|
Bookman, Michael A.
|
|
2017
|
146 |
1 |
p. 58-63
|
artikel
|
| 12 |
Is parametrectomy always necessary in early-stage cervical cancer?
|
Baiocchi, Glauco
|
|
2017
|
146 |
1 |
p. 16-19
|
artikel
|
| 13 |
Management Of Early Stage Cervical Cancer: When Is Non-Randomized Data Good Enough?
|
Lennox, Genevieve K.
|
|
2017
|
146 |
1 |
p. 1-2
|
artikel
|
| 14 |
Managing hereditary breast cancer risk in women with and without ovarian cancer
|
Peters, Mary Linton
|
|
2017
|
146 |
1 |
p. 205-214
|
artikel
|
| 15 |
Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes
|
Frey, Melissa K.
|
|
2017
|
146 |
1 |
p. 123-128
|
artikel
|
| 16 |
Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study
|
Grabosch, Shannon
|
|
2017
|
146 |
1 |
p. 137-145
|
artikel
|
| 17 |
Nonoperative management of atypical endometrial hyperplasia and grade 1 endometrial cancer with the levonorgestrel intrauterine device in medically ill post-menopausal women
|
Baker, William D.
|
|
2017
|
146 |
1 |
p. 34-38
|
artikel
|
| 18 |
Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer
|
Siddiqui, Mohammed Kashif
|
|
2017
|
146 |
1 |
p. 44-51
|
artikel
|
| 19 |
Ovarian cancer spheroid shrinkage following continuous exposure to cisplatin is a function of spheroid diameter
|
Tanenbaum, Laura M.
|
|
2017
|
146 |
1 |
p. 161-169
|
artikel
|
| 20 |
Perioperative sexual interest in women with suspected gynecologic malignancies
|
Bretschneider, C.E.
|
|
2017
|
146 |
1 |
p. 109-113
|
artikel
|
| 21 |
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers
|
Colon-Otero, Gerardo
|
|
2017
|
146 |
1 |
p. 64-68
|
artikel
|
| 22 |
Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma
|
Graybill, Whitney S.
|
|
2017
|
146 |
1 |
p. 11-15
|
artikel
|
| 23 |
Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer
|
Eng, Kevin H.
|
|
2017
|
146 |
1 |
p. 52-57
|
artikel
|
| 24 |
Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience
|
Lee, Jie
|
|
2017
|
146 |
1 |
p. 20-26
|
artikel
|
| 25 |
Quality of life among long-term survivors of advanced stage ovarian cancer: A cross-sectional approach
|
Lutgendorf, Susan K.
|
|
2017
|
146 |
1 |
p. 101-108
|
artikel
|
| 26 |
Quinacrine in endometrial cancer: Repurposing an old antimalarial drug
|
Kalogera, Eleftheria
|
|
2017
|
146 |
1 |
p. 187-195
|
artikel
|
| 27 |
Reporting ‘Denominator’ data is essential for benchmarking and quality standards in ovarian cancer
|
Phillips, Andrew
|
|
2017
|
146 |
1 |
p. 94-100
|
artikel
|
| 28 |
Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
|
Essel, Kathleen G.
|
|
2017
|
146 |
1 |
p. 74-80
|
artikel
|
| 29 |
Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer
|
Park, Jeong-Yeol
|
|
2017
|
146 |
1 |
p. 39-43
|
artikel
|
| 30 |
SYD985, a novel duocarmycin-based HER2-targeting antibody-drug conjugate, shows promising antitumor activity in epithelial ovarian carcinoma with HER2/Neu expression
|
Menderes, Gulden
|
|
2017
|
146 |
1 |
p. 179-186
|
artikel
|
| 31 |
The impact of written information and counseling (WOMAN-PRO II Program) on symptom outcomes in women with vulvar neoplasia: A multicenter randomized controlled phase II study
|
Raphaelis, Silvia
|
|
2017
|
146 |
1 |
p. 114-122
|
artikel
|
| 32 |
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer
|
De Donato, Marta
|
|
2017
|
146 |
1 |
p. 170-178
|
artikel
|
Tijdschrift beschrijving